In vitro pharmacological profile of the A2A receptor antagonist istradefylline

SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

O. ARUNLAKSHANA, H. O. Schild · British Journal of Pharmacology and Chemotherapy · 1959 · 4K citations · Full text

Medicine, Pharmacology, General Pharmacology +16

American Academy of Neurology

&NA; · The Back Letter · 1998 · 386 citations

Medicine, Neurology, Cognitive Neurology +1

Adenosine A_2A Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys

Tomoyuki Kanda, Michael Jackson, Lance A. Smith et al. · Annals of Neurology · 1998 · 356 citations

Medicine, Neuroscience, Pharmacology +16

Adenosine A _2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)

Peter A. LeWitt, Mark Guttman, James W. Tetrud et al. · Annals of Neurology · 2008 · 350 citations

Medicine, Neurology, Pharmacology +13

Adenosine A _2A receptor antagonist treatment of Parkinson’s disease

William Bara‐Jimenez, Ayesha Sherzai, Tzvetelina Dimitrova et al. · Neurology · 2003 · 327 citations

Medicine, Pharmacology, Pharmacotherapy +17